The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as ...
Among the first decisions to be made when initiating a composites testing program is the selection of test methods to follow. Unless performing highly customized testing, it’s usually not difficult to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results